XML 24 R19.htm IDEA: XBRL DOCUMENT v2.3.0.15
STOCK OPTIONS
3 Months Ended
Sep. 30, 2011
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] 
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 14 – STOCK OPTIONS
 
On August 17, 2009, some directors, officers and employees exercised 84,500 options to purchase an aggregate of 84,500 shares of common stock in a cashless manner and received 61,239 shares of common stock as a result of the cashless exercise.
 
On January 3, 2010, the Company made a one-time grant of options to purchase an aggregate of 150,000 shares of common stock to certain officers and directors under the 2009 Equity Incentive Plan at an exercise price of $14.70 per share, the closing price of common stock on the previous trading day. Pursuant to the terms of the grant, one-third of the options vested on February 2, 2010, one-third of the options vested on December 31, 2010 as certain financial targets are achieved and the remaining one-third of the options will vest on December 31, 2011 if certain financial targets are achieved.
 
On January 3, 2010, the Company also made a grant of performance-based options to purchase an aggregate of 45,291 shares of common stock to certain officers and directors under the 2009 Equity Incentive Plan at an exercise price of $14.70 per share, the closing price of the common stock on the previous trading day. Pursuant to the terms of the grant, the options automatically vest in three equal installments on September 30, 2010, 2011 and 2012 because the Company achieved both net sales and income from operations targets for the fiscal year ended June 30, 2010.
 
On February 3, 2010, one independent director resigned and all his vested and unvested options were forfeited pursuant to his grant agreement with the Company.
 
On February 7, 2010, the Company appointed a new independent director and issued to him performance-based options to purchase 10,000 shares of common stock under the 2009 Equity Incentive Plan at an exercise price of $14.02 per share, the closing price of the common stock on the previous trading day. Pursuant to the terms of the grant, one-third of the options vested on March 8, 2010, one-third of the options vested on December 31, 2010 as certain financial targets are achieved and the remaining one-third of the options will vest on December 31, 2011 if certain financial targets are achieved.
 
On March 31, 2011, per compensation board resolution, the Company forfeited all those outstanding unvested options granted to current officers and directors and one former officer on March, 1 2010 and February 7, 2010 according to the 2009 Equity Incentive Plan.
 
The Company’s calculations are made using the Black-Scholes option-pricing model with the following weighted average assumptions: expected life of 2 years; 75.2%-75.6% stock price volatility; risk-free interest rate of 1.63% and no dividends during the expected term. The weighted-average fair value of options granted was $0, $4.37, and $3.29 for the years ended June 30, 2011, 2010, and 2009, respectively. Stock compensation expense is recognized based on awards expected to vest. During the years ended June 30, 2011, 2010 and 2009, the Company recognized stock-based compensation expense of $3,605,235, $1,695,449 and $155,804, respectively.
 
The following table summarizes the options outstanding as of September 30, 2011:
 
         
Weighted
       
         
Average
       
   
Number
   
Exercise
   
Aggregate
 
   
of Shares
   
Price
   
Intrinsic Value
 
Outstanding, June 30, 2009
    121,500     $ 4.49        
Granted
    205,291     $ 14.67        
Forfeited/Canceled
    (22,000 )   $ 9.95        
Exercised
    (109,500 )   $ 4.32        
Outstanding, June 30, 2010
    195,291     $ 14.67        
Granted
    -       -        
Forfeited/Canceled
    (80,192 )   $ 14.67        
Exercised
    -                
Outstanding, June 30, 2011
    115,099     $ 14.66     $ -  
Granted
    -                  
Forfeited/Canceled
    -                  
Exercised
    -                  
Outstanding, September 30, 2011
    115,099     $ 14.66     $ -  
Exercisable, September 30, 2011
    115,099     $ 14.66     $ -